Hair loss treatment guidance highlights genetics and PRP pitfalls

Hair loss, particularly androgenetic alopecia, affects millions worldwide. The condition is driven by the hormone dihydrotestosterone (DHT) and genetic sensitivity, with limited impact from lifestyle or topical products. The American Academy of Dermatology cites 50 million men and 30 million women in the United States alone, while the National Institutes of Health detail the biological mechanism that shortens the hair growth phase.

FDA‑approved treatments such as minoxidil and finasteride are available, but their effectiveness varies. Platelet‑rich plasma (PRP) therapy is promoted for natural hair regeneration, yet success depends on strict adherence to the treatment schedule, proper scalp after‑care, and realistic expectations. Common mistakes include expecting immediate results, missing appointments, ignoring after‑care instructions, and overestimating likely outcomes based on individual genetics and health.

Medical experts stress that accurate diagnosis using scales like Norwood (men) or Ludwig (women) is essential for selecting appropriate interventions and managing patient expectations.